Featuring an interview with Dr Elias Jabbour, including the following topics:
- Evolution of research and therapeutic options for acute lymphoblastic leukemia (ALL) (0:00)
- Clinical and biological characteristics of ALL and implications for prognosis and disease management (6:36)
- Case: A 48-year-old woman with newly diagnosed Philadelphia chromosome-positive (Ph-positive) ALL attains complete remission with ponatinib/blinatumomab (14:03)
- Tolerability and improved quality of life with the chemotherapy-free combination of ponatinib and blinatumomab (24:17)
- Case: A 38-year-old man with newly diagnosed Ph-positive ALL experiences a complete molecular response with induction hyper-CVAD and ponatinib (27:10)
CME information and select publications
Research To Practice | Oncology Videos